CD34+CD38-CD58- Candidate Leukemia-Initiating Cells Are Clinically Relevant With The Unfavorable Prognosis In Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

MLA

kong, Yuan, et al. “CD34+CD38-CD58- Candidate Leukemia-Initiating Cells Are Clinically Relevant With The Unfavorable Prognosis In Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.” Blood, vol. 122, no. 21, Nov. 2013, p. 354. EBSCOhost, https://doi.org/10.1182/blood.V122.21.354.354.

APA

kong, Y., Chang, Y.-J., Liu, Y., Wang, Y., Jiang, Q., Jiang, H., Qin, Y.-Z., Wang, J., Zhu, H.-H., Lai, Y.-Y., Xu, L., Liu, D.-H., & Huang, X.-J. (2013). CD34+CD38-CD58- Candidate Leukemia-Initiating Cells Are Clinically Relevant With The Unfavorable Prognosis In Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Blood, 122(21), 354. https://doi.org/10.1182/blood.V122.21.354.354

Chicago

kong, Yuan, Ying-Jun Chang, Yan-rong Liu, Ya-zhe Wang, Qian Jiang, Hao Jiang, Ya-Zhen Qin, et al. 2013. “CD34+CD38-CD58- Candidate Leukemia-Initiating Cells Are Clinically Relevant With The Unfavorable Prognosis In Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.” Blood 122 (21): 354. doi:10.1182/blood.V122.21.354.354.